Yes | No | Significance* | |||
---|---|---|---|---|---|
n | With stenosis n (%) [95%CI] | n | With stenosis n (%) [95%CI] | ||
Women | 53 | 0 (0%) [NA] | 64 | 8 (12.5%) [4.2-20.8%] | p = 0.008 |
65-74 years of age† | 77 | 6 (7.8%) [1.7-13.9%] | 40 | 2 (5.0%) [0.0-12.1%] | p = 0.570 |
Regular dental‡ | 94 | 5 (5.3%) [0.7-9.9%] | 23 | 3 (13.0%) [0.0-27.9%] | p = 0.188 |
Myocardial infarction | 24 | 4 (16.7%) [0.6-32.7%] | 93 | 4 (4.3%) [0.1-8.5%] | p = 0.032 |
Heart Failure | 6 | 0 (0%) [NA] | 111 | 8 (7.2%) [2.3-12.1%] | p = 0.496 |
Current angina | 17 | 4 (23.5%) [1.1-46.0%] | 100 | 4 (4.0%) [0.1-7.9%] | p = 0.003 |
Symptomatic peripheral artery disease | 4 | 2 (50.0%) [0.0-100%] | 113 | 6 (5.3%) [1.1-9.5%] | p = 0.0005 |
Diabetes | 32 | 3 (9.4%) [0.0-20.1%] | 85 | 5 (5.9%) [0.8-11.0%] | p = 0.505 |
Hypertension | 88 | 8 (9.1%) [3.0-15.2%] | 29 | 0 (0%) [NA] | p = 0.093 |
Current smoking | 21 | 4 (19.0%) [0.7-37.4%] | 96 | 4 (4.2%) [0.1-8.2%] | p = 0.014 |
Blood pressure medicine | 85 | 8 (9.4%) [3.1-15.7%] | 32 | 0 (0%) [NA] | p = 0.072 |
Lipid lowering medicine | 61 | 8 (13.1%) [4.4-21.8%] | 56 | 0 (0%) [NA] | p = 0.005 |
Platelet inhibiting or anticoagulant medicine | 53 | 8 (15.1%) [5.1-25.1%] | 64 | 0 (0%) [NA] | p = 0.0013 |
Any cardiovascular event | 44 | 7 (15.9%) [4.7-27.2%] | 73 | 1 (1.4%) [0.0-4.1%] | p = 0.003 |
Any cardiovascular risk factor | 101 | 8 (7.9%) [2.6-13.3%] | 16 | 0 (0%) [NA] | p = 0.243 |
All | 117 | 8 (6.8%) [2.2-11.5%] | - | - | - |